Digital Look

Welcome to Digital Look++,
you are not logged in

Bristol-Myers Squibb (BMY)

$ 43.39

Hagens Berman Sobol Shapiro: Judge Approves Two ...	29-Sep-2008	PR Newswire
First-Ever National Ranking of 'Hot Spots' for P...	16-Sep-2008	PR Newswire
Ingenuity Systems Announces Multi-Year Deal With...	02-Sep-2008	PR Newswire
Bristol-Myers Squibb Invites Public to Listen to...	30-Apr-2008	PR Newswire
Bristol-Myers Squibb Issues $1.6 Billion of Seni...	29-Apr-2008	PR Newswire
BARACLUDE(R) (Entecavir) Treatment Resulted In G...	26-Apr-2008	PR Newswire
Medarex and Bristol-Myers Squibb Joint Statement...	25-Apr-2008	PR Newswire
Strong Double-Digit Net Sales Growth and Solid E...	24-Apr-2008	PR Newswire
Bristol-Myers Squibb to Announce Results for the...	17-Apr-2008	PR Newswire
U.S. Food and Drug Administration Approves ORENC...	08-Apr-2008	PR Newswire
BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING...	08-Apr-2008	PR Newswire
Repligen Announces Settlement with Bristol-Myers...	08-Apr-2008	PR Newswire
/C O R R E C T I O N -- Bristol-Myers Squibb Com...	24-Mar-2008	PR Newswire
BARACLUDE(R) (entecavir) Data Continue to Demons...	24-Mar-2008	PR Newswire
Bristol-Myers Squibb to Present at Healthcare Co...	17-Mar-2008	PR Newswire
Bristol-Myers Squibb Board Elects Jean-Marc Huet...	05-Mar-2008	PR Newswire
New 300mg Loading Dose Tablet for Plavix(R) Rece...	05-Mar-2008	PR Newswire
Bristol-Myers Squibb Announces Dividend	04-Mar-2008	PR Newswire
U.S. Food and Drug Administration Approves ABILI...	29-Feb-2008	PR Newswire
Great Comebacks(R) Program Announces 2007 Nation...	28-Feb-2008	PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.